0B68 Waldman, Scott - Thomas Jefferson University - Thomas Jefferson University

Scott A. Waldman, MD, PhD

Contact Dr. Waldman

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-6086
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. A novel CDX2 isoform regulates alternative splicing
  2. Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C
  3. Managing the innovation supply chain to maximize personalized medicine
  4. Antiobesity pharmacotherapy: New drugs and emerging targets
  5. Policies to aid the adoption of personalized medicine
  6. Selective antigen-specific CD4+ T-cell, but not CD8+ T- or B-cell, tolerance corrupts cancer immunotherapy
  7. Molecular insights provide the critical path to disease mitigation
  8. Erratum: Cardiopoietic stem cell therapy in heart failure: The C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter randomized trial with lineage-specified biologics (Journal of the American College of Cardiology (2013) 61 (2329-2338))
  9. Genetics and genomics for the prevention and treatment of cardiovascular 05B4 disease: Update a scientific statement from the american heart association
  10. Reply: The C-CURE randomized clinical trial (Cardiopoietic stem Cell therapy in heart failURE)
  11. Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer
  12. Advances in cancer immunotherapy
  13. Colorectal cancer immunotherapy
  14. Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis
  15. Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer: Lessons learned from the us armed forces: Consensus and future directions
  16. Molecular staging of node negative patients with colorectal cancer
  17. Systems approaches evolve clinical pharmacology
  18. Cardiopoietic stem cell therapy in heart failure: The C-CURE (cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics
  19. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine
  20. New advances in models and strategies for developing anti-obesity drugs